Jonny Kinzi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Induced Pluripotent Stem Cells

Top Venues

The Journal of pharmacology and experimental therapeutics

Drug metabolism and disposition: the biological fate of chemicals

Clinical and translational science

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Jonny Kinzi, Janine Hussner, Isabell Seibert, Mirubagini Vythilingam, Celina Vonwyl, Clarisse Gherardi, Pascal Detampel, Oliver Schwardt, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Impact of OATP2B1 on pharmacokinetics of atorvastatin investigated in rSlco2b1 -knockout and SLCO2B1 -knockin rats. Drug metabolism and disposition: the biological fate of chemicals (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Jonny Kinzi, Janine Hussner, Isabell Seibert, Mirubagini Vythilingam, Celina Vonwyl, Clarisse Gherardi, Pascal Detampel, Oliver Schwardt, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in rSlco2b1 -Knockout and SLCO2B1 -Knockin Rats. Drug metabolism and disposition: the biological fate of chemicals 52 (9) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in rats increases rCYP3A1 protein expression but not the metabolism of erlotinib to OSI-420 . The Journal of pharmacology and experimental therapeutics (2024)
Jonny Kinzi, Janine Hussner, Anima M Schaefer, Andrea Treyer, Isabell Seibert, Annika Tillmann, Vanessa Mueller, Clarisse Gherardi, Celina Vonwyl, Matthias Hamburger, Henriette E Meyer Zu Schwabedissen
Influence of Slco2b1-knockout and SLCO2B1-humanization on coproporphyrin I and III levels in rats. British journal of pharmacology (2023)
Jonny Kinzi, Markus Grube, Karin Brecht, Isabell Seibert, Werner Siegmund, Henriette E Meyer Zu Schwabedissen
Various effects of repeated rifampin dosing on coproporphyrin levels in humans. Clinical and translational science (2023)